Global Depression Treatment Market Size Hit USD 14.12 Billion at a CAGR of 2.6% in 2030

The global depression treatment market size was USD 11.20 Billion in 2021 and is expected to register a revenue CAGR of 2.6% during the forecast period, according to latest analysis by Reports and Data. Rising launch of innovative drugs with less side effects is a major factor expected to drive market revenue growth during the forecast period. Depression treatments are given to alleviate symptoms of anxiety disorders, mild chronic depression, and Major Depressive Disorder (MDD). In addition, rising prevalence of depression among global population is also driving revenue growth of the market. Improvement of people’s health and well-being is achieved through identification of new or enhanced health policies, systems, services, technology, products, and delivery methods. For therapeutic purposes, modern gadgets and cell phones can report a significant amount of pertinent patient data. For example, over four billion individuals use social media on a global scale, creating huge amounts of information from their devices. An increasing body of research indicates that language usage and visual elements in postings can reveal and forecast mental health issues of specific people as well as assess general population trends. Researchers, tech companies, government agencies, and nongovernmental organizations can use these enormous databases to look for signs of mental health conditions, such as depression, anxiety, and suicide risk, owing to advancements in Artificial Intelligence (AI), Natural Language Processing (NLP), and other data science tools.

To help people with epilepsy identify seizures early, apps such as Embrace and myCareCentric Epilepsy, use wristbands to analyze heart rate, skin conductance, and movements. Monitoring patient’s app interactions is another popular method of gaining access to mental wellness. For example, Takeda Pharmaceuticals and Cognition Kit introduced an Apple Watch app for tracking patients with depressive illnesses’ daily mood, and cognition. Majority of Internet of Medical Things (IoMT) solutions for mental health are non-invasive, which creates a huge opportunity for companies that specialize in mental health prevention, screening, evaluation, and therapy.

However, lack of awareness, delay in diagnosis, high cost of therapies, lack of skilled experts and treatment centers in emerging countries, and adverse effects of depression treatment drugs are factors expected to hamper market revenue growth.

Some major companies operating in the global market report include Pfizer Inc., Lyra Health, Inc., NeuroFlow, Quartet, H. Lundbeck A/S, Sanofi, AstraZeneca, Bristol-Myers Squibb Company, Eli Lilly and Company, and Takeda Pharmaceutical Company Limited.

Get a sample of the report @ https://www.reportsanddata.com/download-free-sample/5907

Market Overview:

The research report assesses the market dynamics, market landscape, company profiles, production and manufacturing capacity, year-on-year growth rate, SWOT analysis, and Porter’s Five Forces analysis. The report estimates the market size, market growth, and provides an accurate forecast for the key segments of the market for the forecast period of 2022-2030. The report also covers an in-depth analysis of the key competitors of the market, along with their growth strategies and business expansion plans.

The Depression Treatment Market has been segmented into key regions of the world and offers an analysis of growth rate, market share, market size, current and emerging trends, production and consumption ratio, industrial chain analysis, demand and supply, import and export, revenue contribution, and presence of key players in each region. A country-wise analysis of the market is offered in the report to gain a better understanding of the regional spread and progress of the Depression Treatment Market.

Further key findings from the report suggest,

• The geriatric segment accounted for a significant revenue share in 2021. People develop several stress-related diseases as they age due to a reduction in functional capacity. Retirement also lowers socioeconomic status of elderly, which worsens situation and encourages isolation and loneliness.
• The mental health centers segment is expected to register largest revenue CAGR during the forecast period. Risk of chronic illnesses linked to stress, anxiety, and substance addiction is decreased by mental health services provided in these centers. Mental health treatments improve perspective of people who might feel lost and hopeless while also saving lives.
• The North America market accounted for largest revenue share in 2021. This is attributed to favorable government policies and region’s rising rates of anxiety disorders, depression, and sadness. In the U.S., there are more cases of depression disorder. Statistics and figures from Anxiety and Depression Foundation show that 6.8 million adults in the U.S., or 3.1% of population, suffer from generalized anxiety disorder, which is also expected to drive revenue growth of the market in this region.

To understand how our Depression Treatment Market can bring difference to your business strategy:– https://www.reportsanddata.com/report-detail/depression-treatment-market

For the purpose of this report, Reports and Data has segmented the global Depression Treatment Market based on application, product, and region

Age Group Outlook (Revenue, USD Billion; 2019-2030)

• Adolescents
• Adults

• Geriatric

Drug Type Outlook (Revenue, USD Billion; 2019-2030)

• Antidepressants
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Tricyclic Antidepressants (TCAs)
  • Serotonin and Noradrenaline Reuptake Inhibitors (SNRIs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Norepinephrine and Dopamine Reuptake Inhibitors (NDRIs)
  • Non-Competitive N-methyl-D-aspartate Receptor Antagonists
• Antipsychotics
• Beta-blockers
• Others

Application Outlook (Revenue, USD Billion; 2019-2030)

• Major Depressive Disorder (MDD)
• Bipolar Disorder
• Seasonal Affective Disorder
• Dysthymia
• Postpartum Depression
• Psychotic Depression
• Others

End-Use Outlook (Revenue, USD Billion; 2019-2030)

• Mental Health Centers
• Hospitals & Clinics
• NGOs
• Asylum
• Others

Regional Outlook (Revenue, USD Billion; 2019-2030)

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Sweden
  • BENELUX
  • Rest of Europe
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of APAC
• Latin America
  • Brazil
  • Rest of LATAM
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Israel
  • Rest of MEA

Request a customization of the report : https://www.reportsanddata.com/request-customization-form/5907

 Key Advantages of Depression Treatment Market Report:

• Identification and analysis of the market size and competition
• Qualitative and quantitative analysis of the market data
• Data validated by industry experts after extensive primary and secondary research
• Extensive regional analysis of the Depression Treatment industry
• Profiling of key players along with their business overview, business strategies, deals and partnerships, and product portfolio
• SWOT and Porter’s Five Forces Analysis for in-depth understanding of the competitive landscape
• Feasibility analysis and investment analysis to enable strategic investment decisions
• Analysis of opportunities, drivers, restraints, challenges, risks, and limitations

Conclusively, all aspects of the Depression Treatment Market are quantitatively as well qualitatively assessed to study the global as well as regional market comparatively. This market study presents critical information and factual data about the market providing an overall statistical study of this market on the basis of market drivers, limitations and its future prospects.

About Us:

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

Contact Us:

John W
Head of Business Development
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Reports and Data | Web: www.reportsanddata.com
Check our upcoming research reports @ https://www.reportsanddata.com/upcoming-reports
Visit our blog for more industry updates @ https://www.reportsanddata.com/blogs

Image Credit

Browse More Reports:

https://www.biospace.com/article/targeted-rna-sequencing-market-size-share-growth-trends-growth-analysis-by-2021-2028/

https://www.biospace.com/article/vaginal-pessary-market-size-growth-research-physical-characteristics-applications-and-forecast-analysis-by-2021-2028/

https://www.biospace.com/article/increased-research-in-the-field-of-genomics-and-bioinformatics-as-well-as-increased-development-and-commercialization-of-new-drugs-are-some-of-key-factors-driving-phenylketonuria-pku-treatment-market-rnd/

https://www.biospace.com/article/intra-oral-scanners-for-digital-impression-market-trends-2021-industry-size-share-growth-and-forecast-analysis-by-2028-rnd/

https://www.biospace.com/article/rising-number-of-diabetes-cases-around-the-world-has-created-a-demand-for-self-injection-systems-reports-and-data/

The post Global Depression Treatment Market Size Hit USD 14.12 Billion at a CAGR of 2.6% in 2030 appeared first on Market O Graphics.